July 23, 2016 7:59 AM ET


Company Overview of Tobira Therapeutics, Inc.

Company Overview

Tobira Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat liver disease, inflammation, fibrosis, and HIV. Its lead product candidate includes cenicriviroc, an immunomodulator and dual inhibitor of CCR2 and CCR5, which is in Phase 2a study for the treatment of primary sclerosing cholangitis and non-alcoholic steatohepatitis disease; and Phase 2b study for HIV. The company was founded in 2006 and is headquartered in South San Francisco, California.

701 Gateway Boulevard

Suite 300

South San Francisco, CA 94080

United States

Founded in 2006

22 Employees



Key Executives for Tobira Therapeutics, Inc.

Chief Executive Officer and Director
Age: 52
Total Annual Compensation: $460.9K
Chief Financial Officer and Head of Corporate Development
Age: 37
Total Annual Compensation: $305.3K
Chief Medical Officer
Age: 52
Total Annual Compensation: $459.7K
Compensation as of Fiscal Year 2015.

Tobira Therapeutics, Inc. Key Developments

Tobira Therapeutics' Cenicriviroc Shows Anti-Inflammatory Activity in Liver, Kidneyy

Tobira Therapeutics announced multiple animal models of cenicriviroc, or CVC, showed anti-inflammatory and anti-fibrotic activity in organs including liver and kidney.

Tobira Therapeutics, Inc. Presents at Jefferies 2016 Healthcare Conference, Jun-09-2016 04:30 PM

Tobira Therapeutics, Inc. Presents at Jefferies 2016 Healthcare Conference, Jun-09-2016 04:30 PM. Venue: The Grand Hyatt Hotel, New York, New York, United States.

Tobira Therapeutics, Inc. Presents at Boston CEO Conference, May-31-2016 04:30 PM

Tobira Therapeutics, Inc. Presents at Boston CEO Conference, May-31-2016 04:30 PM. Venue: Four Seasons Boston, 200 Boylston Street, Boston, MA 02116, United States. Speakers: Laurent Fischer, Chief Executive Officer and Director.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Tobira Therapeutics, Inc., please visit www.tobiratherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.